Hubei Xingfa Chemicals Group Co., Ltd.

XSSC:600141 Stock Report

Market Cap: CN¥25.1b

Hubei Xingfa Chemicals Group Valuation

Is 600141 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600141 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 600141 (CN¥22.73) is trading below our estimate of fair value (CN¥65.45)

Significantly Below Fair Value: 600141 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600141?

Key metric: As 600141 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600141. This is calculated by dividing 600141's market cap by their current earnings.
What is 600141's PE Ratio?
PE Ratio14.4x
EarningsCN¥1.74b
Market CapCN¥25.08b

Price to Earnings Ratio vs Peers

How does 600141's PE Ratio compare to its peers?

The above table shows the PE ratio for 600141 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.1x
600299 Bluestar Adisseo
26.5x17.7%CN¥28.9b
300699 Weihai Guangwei Composites
31x16.6%CN¥26.9b
000683 Inner Mongolia Yuan Xing Energy
11.8x23.7%CN¥20.2b
002080 Sinoma Science & TechnologyLtd
18.8x31.1%CN¥21.2b
600141 Hubei Xingfa Chemicals Group
14.4x16.8%CN¥25.1b

Price-To-Earnings vs Peers: 600141 is good value based on its Price-To-Earnings Ratio (14.4x) compared to the peer average (22.1x).

Price to Earnings Ratio vs Industry

How does 600141's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
600141 14.4xIndustry Avg. 35.6xNo. of Companies42PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 600141 is good value based on its Price-To-Earnings Ratio (14.4x) compared to the CN Chemicals industry average (35.9x).

Price to Earnings Ratio vs Fair Ratio

What is 600141's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600141 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.4x
Fair PE Ratio20.8x

Price-To-Earnings vs Fair Ratio: 600141 is good value based on its Price-To-Earnings Ratio (14.4x) compared to the estimated Fair Price-To-Earnings Ratio (20.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600141 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥22.73
CN¥26.61
+17.1%
4.0%CN¥28.00CN¥25.05n/a4
Nov ’25CN¥23.34
CN¥26.61
+14.0%
4.0%CN¥28.00CN¥25.05n/a4
Oct ’25CN¥22.50
CN¥23.53
+4.6%
10.9%CN¥25.05CN¥19.08n/a4
Sep ’25CN¥18.83
CN¥23.04
+22.4%
12.2%CN¥25.05CN¥19.08n/a3
Aug ’25CN¥18.32
CN¥24.88
+35.8%
0.8%CN¥25.05CN¥24.60n/a3
Jul ’25CN¥19.65
CN¥24.88
+26.6%
0.8%CN¥25.05CN¥24.60n/a3
Jun ’25CN¥21.61
CN¥24.91
+15.3%
0.7%CN¥25.05CN¥24.60n/a4
May ’25CN¥21.52
CN¥24.91
+15.8%
0.7%CN¥25.05CN¥24.60n/a4
Apr ’25CN¥19.02
CN¥23.77
+25.0%
7.3%CN¥25.00CN¥21.32n/a3
Mar ’25CN¥19.40
CN¥23.64
+21.9%
8.1%CN¥25.00CN¥20.93n/a3
Feb ’25CN¥16.10
CN¥23.64
+46.9%
8.1%CN¥25.00CN¥20.93n/a3
Jan ’25CN¥18.25
CN¥23.64
+29.6%
8.1%CN¥25.00CN¥20.93n/a3
Dec ’24CN¥18.82
CN¥23.64
+25.6%
8.1%CN¥25.00CN¥20.93n/a3
Nov ’24CN¥19.66
CN¥22.97
+16.8%
8.9%CN¥25.00CN¥20.93CN¥23.342
Oct ’24CN¥19.77
CN¥33.79
+70.9%
28.4%CN¥44.00CN¥23.46CN¥22.504
Sep ’24CN¥20.69
CN¥33.79
+63.3%
28.4%CN¥44.00CN¥23.46CN¥18.834
Aug ’24CN¥24.30
CN¥36.76
+51.3%
18.3%CN¥44.00CN¥28.35CN¥18.324
Jul ’24CN¥22.22
CN¥36.76
+65.4%
18.3%CN¥44.00CN¥28.35CN¥19.654
Jun ’24CN¥21.63
CN¥36.76
+70.0%
18.3%CN¥44.00CN¥28.35CN¥21.614
May ’24CN¥24.70
CN¥36.76
+48.8%
18.3%CN¥44.00CN¥28.35CN¥21.524
Apr ’24CN¥30.45
CN¥38.77
+27.3%
12.0%CN¥44.00CN¥33.38CN¥19.024
Mar ’24CN¥35.27
CN¥40.75
+15.5%
15.4%CN¥48.78CN¥33.48CN¥19.403
Feb ’24CN¥32.50
CN¥40.75
+25.4%
15.4%CN¥48.78CN¥33.48CN¥16.103
Jan ’24CN¥29.00
CN¥40.75
+40.5%
15.4%CN¥48.78CN¥33.48CN¥18.253
Dec ’23CN¥31.02
CN¥40.75
+31.4%
15.4%CN¥48.78CN¥33.48CN¥18.823
Nov ’23CN¥29.12
CN¥40.75
+39.9%
15.4%CN¥48.78CN¥33.48CN¥19.663

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yunnan Yuntianhua

CN¥39.9b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥21.90

7D

-1.7%

1Y

37.1%

Western MiningLtd

CN¥39.7b

Engages in the mining, smelting, and trading of metals in Mainland China and internationally.

601168

CN¥16.68

7D

-4.5%

1Y

29.6%

MeiHua Holdings GroupLtd

CN¥28.8b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.10

7D

-2.2%

1Y

7.0%